Tolerance development of 8α,9α- and 8β,9β- epoxyhexahydrocannabinols in the mouse

S. Narimatsu, K. Watanabe, I. Yamamoto, H. Yoshimura

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Seven daily administrations of 8α,9α- and 8β,9β-epoxyhexahydrocannabinols (EHHCs) (10 mg/kg, i.v. and 5 mq/kg, i.v., respectively, once a day) developed tolerance to their pharmacological effects such as hypothermia, catalepsy and pentobarbital-induced sleep prolongation in the mouse. Comparing with the effect obtained on the 1st day, the significant reduction was observed on the 3rd to 4th day of EHHCs treatments. Tolerant mice received EHHCs for 3 consecutive days showed cross-tolerance to Δ8-tetrahydrocannabinol (THC) in all the pharmacological indices. Furthermore, EHHCs-tolerant mice were also cross-tolerant to hypothermic effect of chlorpromazine. On the other hand, 8β,9β-EHHC-tolerant, but not 8α,9α-EHHC-tolerant mice showed cross-tolerance to hypothermia induced with morphine. These results suggest that both epoxides may contribute to the tolerance development to Δ8-THC as active metabolites at least in part.

Original languageEnglish
Pages (from-to)301-314
Number of pages14
JournalResearch Communications in Substances of Abuse
Volume4
Issue number4
Publication statusPublished - 1983
Externally publishedYes

Fingerprint

Dronabinol
Pharmacology
Catalepsy
Induced Hypothermia
Epoxy Compounds
Chlorpromazine
Pentobarbital
Hypothermia
Morphine
Sleep
Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Tolerance development of 8α,9α- and 8β,9β- epoxyhexahydrocannabinols in the mouse. / Narimatsu, S.; Watanabe, K.; Yamamoto, I.; Yoshimura, H.

In: Research Communications in Substances of Abuse, Vol. 4, No. 4, 1983, p. 301-314.

Research output: Contribution to journalArticle

Narimatsu, S, Watanabe, K, Yamamoto, I & Yoshimura, H 1983, 'Tolerance development of 8α,9α- and 8β,9β- epoxyhexahydrocannabinols in the mouse', Research Communications in Substances of Abuse, vol. 4, no. 4, pp. 301-314.
Narimatsu, S. ; Watanabe, K. ; Yamamoto, I. ; Yoshimura, H. / Tolerance development of 8α,9α- and 8β,9β- epoxyhexahydrocannabinols in the mouse. In: Research Communications in Substances of Abuse. 1983 ; Vol. 4, No. 4. pp. 301-314.
@article{a0a96115f8f247748d9fde32cbca9554,
title = "Tolerance development of 8α,9α- and 8β,9β- epoxyhexahydrocannabinols in the mouse",
abstract = "Seven daily administrations of 8α,9α- and 8β,9β-epoxyhexahydrocannabinols (EHHCs) (10 mg/kg, i.v. and 5 mq/kg, i.v., respectively, once a day) developed tolerance to their pharmacological effects such as hypothermia, catalepsy and pentobarbital-induced sleep prolongation in the mouse. Comparing with the effect obtained on the 1st day, the significant reduction was observed on the 3rd to 4th day of EHHCs treatments. Tolerant mice received EHHCs for 3 consecutive days showed cross-tolerance to Δ8-tetrahydrocannabinol (THC) in all the pharmacological indices. Furthermore, EHHCs-tolerant mice were also cross-tolerant to hypothermic effect of chlorpromazine. On the other hand, 8β,9β-EHHC-tolerant, but not 8α,9α-EHHC-tolerant mice showed cross-tolerance to hypothermia induced with morphine. These results suggest that both epoxides may contribute to the tolerance development to Δ8-THC as active metabolites at least in part.",
author = "S. Narimatsu and K. Watanabe and I. Yamamoto and H. Yoshimura",
year = "1983",
language = "English",
volume = "4",
pages = "301--314",
journal = "Research Communications in Substances of Abuse",
issn = "0193-0818",
publisher = "PJD Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Tolerance development of 8α,9α- and 8β,9β- epoxyhexahydrocannabinols in the mouse

AU - Narimatsu, S.

AU - Watanabe, K.

AU - Yamamoto, I.

AU - Yoshimura, H.

PY - 1983

Y1 - 1983

N2 - Seven daily administrations of 8α,9α- and 8β,9β-epoxyhexahydrocannabinols (EHHCs) (10 mg/kg, i.v. and 5 mq/kg, i.v., respectively, once a day) developed tolerance to their pharmacological effects such as hypothermia, catalepsy and pentobarbital-induced sleep prolongation in the mouse. Comparing with the effect obtained on the 1st day, the significant reduction was observed on the 3rd to 4th day of EHHCs treatments. Tolerant mice received EHHCs for 3 consecutive days showed cross-tolerance to Δ8-tetrahydrocannabinol (THC) in all the pharmacological indices. Furthermore, EHHCs-tolerant mice were also cross-tolerant to hypothermic effect of chlorpromazine. On the other hand, 8β,9β-EHHC-tolerant, but not 8α,9α-EHHC-tolerant mice showed cross-tolerance to hypothermia induced with morphine. These results suggest that both epoxides may contribute to the tolerance development to Δ8-THC as active metabolites at least in part.

AB - Seven daily administrations of 8α,9α- and 8β,9β-epoxyhexahydrocannabinols (EHHCs) (10 mg/kg, i.v. and 5 mq/kg, i.v., respectively, once a day) developed tolerance to their pharmacological effects such as hypothermia, catalepsy and pentobarbital-induced sleep prolongation in the mouse. Comparing with the effect obtained on the 1st day, the significant reduction was observed on the 3rd to 4th day of EHHCs treatments. Tolerant mice received EHHCs for 3 consecutive days showed cross-tolerance to Δ8-tetrahydrocannabinol (THC) in all the pharmacological indices. Furthermore, EHHCs-tolerant mice were also cross-tolerant to hypothermic effect of chlorpromazine. On the other hand, 8β,9β-EHHC-tolerant, but not 8α,9α-EHHC-tolerant mice showed cross-tolerance to hypothermia induced with morphine. These results suggest that both epoxides may contribute to the tolerance development to Δ8-THC as active metabolites at least in part.

UR - http://www.scopus.com/inward/record.url?scp=0021003454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021003454&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0021003454

VL - 4

SP - 301

EP - 314

JO - Research Communications in Substances of Abuse

JF - Research Communications in Substances of Abuse

SN - 0193-0818

IS - 4

ER -